Send Inquiry

Request To Call Back

Natalizumab Injection

Get a Price/Quote

MOQ : 10 Boxes

Natalizumab Injection Specification

Molecular Formula
C6452H9976N1720O2014S40

Grade
Pharmaceutical Grade

Application
Hospital, Clinical, Personal

CAS No
189261-10-7

Purity
99%

Formulations Type
Injectables

Formulations Form
Liquid

Treatments & Functions
Used to treat Multiple Sclerosis (MS) and Crohns Disease

Gender/Age Group
Adult

Dosage Guidelines
As directed by physician

Volume
15 ml

Storage Instructions
Store in Cool

Manufactured By
Reputed Manufacturer

Brand Name
Natalizumab

Expiry
24 months from manufacture

Prescription/Non Prescription
Prescription

Packaging Type
Vial

Appearance
Clear to slightly opalescent, colorless to pale yellow liquid

Strength
300mg/15ml

Route of Administration
Intravenous

Natalizumab Injection Trade Information

Minimum Order Quantity
10 Boxes

FOB Port
Mundra Port

Payment Terms
Letter of Credit (L/C), Telegraphic Transfer (T/T), Western Union, Paypal, Letter of Credit at Sight (Sight L/C), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
10000 Boxes Box Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Buyer Requirements

Main Domestic Market
All India

Certifications
ISO, GMP, WHO

About Natalizumab Injection

Natalizumab Injection

Product Description
This Natalizumab Injection is a recombinant humanized monoclonal antibody, produced in murine myeloma cells. We are the leading exporter of the medicines, hence, make sure to inspect the quality of the stock on various standard parameters. The medication is widely recommended for preventing the symptoms and slowing down the worsening of disability in people who have relapsing-remitting forms of multiple sclerosis. Our clients can get this Natalizumab Injection from us at highly competitive price.

Key points:

The medication is especially recommended to people who were not helped by other medications for MS
It is also effective in people who have Crohn's disease
It belongs to a class of medications called immunomodulators

Specifications:

Brand: Tysabri
Contain: Natalizumab Inj
strength : 300mg
Packing: Vail

Targeted Therapy for MS and Crohns Disease

Natalizumab Injection delivers effective relief by blocking inflammatory cell migration, providing substantial symptom management for patients with Multiple Sclerosis and Crohns Disease. Its precisely formulated composition, designed for adult use, aids in mitigating disease progression and improving quality of life when administered intravenously by healthcare professionals.

Pharmaceutical Quality and Safety Assured

Every batch of Natalizumab is manufactured under strict quality controls, adhering to pharmaceutical grade standards (99% purity). The product is supplied in a tamper-evident vial, ensuring safety from packaging to administration. With an expiry of 24 months from the date of manufacture, users are assured lasting potency and reliability.

FAQs of Natalizumab Injection:

Q: How should Natalizumab Injection be administered for optimal results?

A: This medication must be administered intravenously by a healthcare professional within a hospital or clinical setting. Dosage and frequency are determined by the treating physician based on the patients condition and medical history.

Q: What is the primary benefit of using Natalizumab for patients?

A: Natalizumab is highly effective in reducing the progression of Multiple Sclerosis and Crohns Disease by preventing harmful immune cells from reaching affected areas, thus decreasing relapses and improving symptom control.

Q: When should Natalizumab Injection not be used?

A: Natalizumab Injection should be avoided if the patient has experienced severe allergic reactions to similar medications, or if the treating physician advises against it due to specific health concerns. Always consult a specialist before use.

Q: Where is Natalizumab Injection typically stored to maintain its efficacy?

A: The injection must be stored in cool conditions as per the storage instructions, away from direct sunlight, to preserve its pharmaceutical integrity and prevent degradation.

Q: What should patients expect during the treatment process with Natalizumab?

A: Patients will receive Natalizumab via intravenous infusion under medical supervision. Regular monitoring and follow-up visits will be scheduled to ensure efficacy and manage any side effects that may arise.

Q: How does the packaging type support the integrity of Natalizumab?

A: Natalizumab is supplied in a secure, pharmaceutical-grade vial with clear labeling, designed to maintain sterility and prevent contamination throughout handling and storage.

Tell us about your requirement